1. Introduction {#sec1}
===============

Ion channels are comprised of a large variety of differing families of pore proteins. Initially, ion channels were mostly known for their role in the nervous system where they play a crucial role in the signal transmission over neurites and synapses. But in fact they are involved in numerous other cellular processes including cell size regulation, muscle contractions, immune system activation \[[@B1]\], or hormone release \[[@B2]\]. Distinct ion channels are furthermore recognized to be of high importance for excitable cells of the heart: cardiomyocytes of the working myocardium as well as cells of the cardiac conduction system. In the heart, specific ion channels are responsible, for example, for the regulated generation of action potentials and for cardiac muscle contraction strength and time \[[@B3]\]. Additionally, ion channels play an important role in several differentiation and maturation processes \[[@B4]--[@B6]\]. The presented study aims to take a closer look at ion channel expression in human-induced pluripotent stem cells (hiPSCs) to give a start point for further analyses of their distinct roles at an early developmental cell state and differentiation processes.

hiPSCs are generated from somatic cells by timed overexpression of specific transcription factors and strongly resemble pluripotent embryonic stem cells \[[@B7], [@B8]\]. Pluripotency is amongst others defined by the ability to differentiate into cells of all three germ layers and unlimited symmetrical cell division. This cell system is widely utilized for studies investigating developmental processes or disease mechanisms \[[@B9], [@B10]\]. Although it has become clear that differentiation processes influence ion channel expression \[[@B11]\], the distinct role of ion channels during these processes is so far only poorly understood. Nevertheless, it became evident that certain ion channels play a pivotal role in stem cell biology, including cell fate determination, cell cycle regulation, or cytoskeletal reorganization \[[@B6], [@B12]--[@B15]\].

The possibilities of iPSCs include the generation of individual or patient-specific-pluripotent cells, which can be subsequently differentiated into the affected cell types. This is already utilized to study pathomechanisms in a variety of tissues and cell types \[[@B9], [@B16]--[@B18]\]. The so-called channelopathies which are based on mutations in ion channels are the cause of developmental disorders and are the subject of various studies \[[@B19], [@B20]\]. To elucidate the role of ion channels in cell differentiation, maturation or their role in pathomechanisms a well-founded knowledge of ion channel distribution in pluripotent cells, representing one of the earliest stages of development, is indispensable. In that respect, we compared the expression levels of several ion channels in human keratinocytes with their reprogrammed progeny, hiPSCs. Keratinocytes derived from plucked human hair \[[@B21], [@B22]\] represent one of the most promising cell sources for the generation of the investigated hiPSCs \[[@B23]\]. We have elucidated ion channel regulation for various channel families and their subtypes. Additionally, we compared the expression levels of ion channel families and subtypes, found to be regulated during reprogramming, with iPSC-differentiated progeny, namely, neurons and cardiomyocytes. These comparisons could be a start point to evaluate the contribution and function of different ion channels, for example, for self-renewal and differentiation processes in stem cells.

2. Material and Methods {#sec2}
=======================

2.1. Ethical Statement and Donor Information {#sec2.1}
--------------------------------------------

After informed consent was given by the donors (ethical agreement by the University of Ulm, number 88/12) hair with intact hair roots was gathered by plucking from the scalp after desinfection. We used hair from healthy volunteers (age between 24 to 45 and both male and female gender).

2.2. hiPSC Generation and Cell Culture {#sec2.2}
--------------------------------------

Keratinocytes were obtained from plucked human scalp hair as already described \[[@B22]\]. Keratinocytes were propagated in EpiLife medium with HKGS supplement (both Invitrogen, Carlsbad, CA, USA). hiPSCs were generated from keratinocytes by lentiviral transduction of four reprogramming factors (Oct4, Sox2, Klf4, and cMyc) as described earlier \[[@B23]\]. After the reprogramming on rat embryonic fibroblasts they were maintained feeder-free on Matrigel (BD Biosciences, Franklin Lakes, NJ, USA) coated dishes in mTeSR1 medium (Stemcell Technologies, Vancouver, CA, USA).

2.3. Gene Expression Microarrays {#sec2.3}
--------------------------------

Gene expression microarrays were performed for 6 keratinocyte samples and 9 hiPSC samples with the Agilent Whole Human Genome Microarray Kit (4x44k microarray kit G4112F, Agilent Technologies, Santa Clara, CA, USA). 500 ng of total RNA was used to produce Cy3-CTP-labeled cRNA with the Agilent Low RNA Input Liner Amplification Kit. The cRNA was purified and 1,65 *μ*g per array was hybridized for 17 h at 65°C and 10 r.p.m. Afterwards, the arrays were washed with Agilent Gene Expression Wash Buffers one and two and finally with acetonitrile for 1 min. The slides were scanned using Scan Control 7.0 software with a resolution of 5 *μ*m. Scan data was extracted with the Feature Extraction 9.1 software. Expression levels were background adjusted and quantile normalized with the GeneSpring GX 12 software. Differential expression between keratinocytes and hiPSCs was analyzed using student\'s *t*-test. A fold change \> 2 and a *P* value \< 0.05 was considered significant and highlighted bold (upregulation) or italic (downregulation) in the results table. For comparisons of iPSCs with iPSC-derived neurons published data from GSE34879 (GSM856936, GSM856937, GSM856915, GSM856916) and for cardiomyocytes GSE17579 (GSM438022, GSM438026, GSM438034, GSM438021, GSM438032, GSM438036) were used (both from NCBI Gene Expression Omnibus, <http://www.ncbi.nlm.nih.gov/geo/>). Fold change is shown if \>2.

3. Results {#sec3}
==========

3.1. Differential Expression of Ion Channels in hiPSCs Compared to Keratinocytes {#sec3.1}
--------------------------------------------------------------------------------

We first compared the expression of various ion channel families from keratinocytes to hiPSCs and from hiPSCs to cardiomyocytes and neurons, respectively. From the 387 probes ([Table 1](#tab1){ref-type="table"}) binding in ion channel genes from parental keratinocytes to hiPSCs, 101 (26%) showed a significant increase in expression (fold change \> 2, *P* \< 0.05; labeled in bold) while 23 (6%) showed a significant decrease (fold change \> −2, *P* \< 0.05; labeled in italic). In a second step differentially regulated ion channels from hiPSCs to hiPSC-derived neurons were investigated and we found 29 ion channel transcripts to be upregulated (fold change \> 2; labeled in bold) while 6 showed a significant decrease (fold change \> −2; labeled in italic). For cardiomyocytes, mRNA levels of only 7 ion channel members were upregulated (fold change \> 2; labeled in bold) and 10 mRNA levels showed a significant decrease (fold change \> −2; labeled in italic).

3.2. Voltage-Gated Calcium Channels {#sec3.2}
-----------------------------------

Voltage-gated calcium channels are crucially involved in the Ca^2+^-influx thereby playing an important role in calcium signaling of virtually all cells. High-voltage-gated calcium channels include the neural N-type channel, the poorly defined brain-specific R-type channel, the closely related P/Q-type channel, and the dihydropyridine-sensitive L-type channels responsible for excitation-contraction coupling of skeletal, smooth, and cardiac muscles as well as for hormone secretion in endocrine cells (reviewed in \[[@B24]\]). While mainly permeable for calcium ions they also show a low permeability for sodium ions. Upon depolarization of the cell they mediate a calcium influx into the cell. The channels consist of the main alpha subunit as well as regulatory beta, alpha 2/delta, and gamma subunits. The *α* ~1~ subunit forms the ion conducting pore while the associated subunits have several functions including modulation of gating \[[@B25]\].*CACNA1A* mutations are for example involved in ataxia \[[@B26]\]. We have analyzed their expression with 42 probes. During reprogramming 14 (33%) of them are significantly upregulated while only 1 (2%) is significantly downregulated. From iPSCs to neurons, as expected, neuronal alpha-subunits *CACNA1D, CACNA1E*areupregulated together with several neuronal channel subunits (*α* ~2~ *δ*, *β*, and *γ*). In cardiomyocytes, solely the alpha subunit of the cardiac *CACNA1C*is upregulated. Of note, none of the differentiated progeny downregulated any voltage-gated calcium channels.

3.3. Sperm-Associated Cation Channels {#sec3.3}
-------------------------------------

Sperm-associated cation channels or CatSper channels are calcium ion channels. They are flagellar proteins involved in sperm motility and therefore affect fertility \[[@B27]\]. During reprogramming to iPSCs, from seven used probes just one showed a significant downregulation and none had a significant upregulation. We observed nothing noteworthy in the differentiated progeny.

3.4. Nicotinic Acetylcholine Receptors {#sec3.4}
--------------------------------------

Nicotinic acetylcholine receptors play a role in interneuronal synapses and neuromuscular junctions. They are composed of five subunits as homomeric or heteromeric receptors. They are located at the postsynaptic site and upon binding of acetylcholine they allow the transmission of cations, especially sodium and potassium ions, in some versions also calcium ions. This leads to a depolarization of the membrane and triggers further signaling pathways \[[@B28]\]. Several acetylcholine receptors and subunits are thought to play roles in a variety of pathomechanisms, for example, psychiatric disorders, cardiovascular diseases, or cancer \[[@B29]--[@B31]\]. From 21 probes, 5 (24%) showed a significant upregulation while 3 (14%) showed a significant downregulation from keratinocytes to iPSCs. In neurons, solely the neuronal nicotinic acetylcholine receptor *CHRNA6* alpha subunit was upregulated, none in cardiomyocytes.

3.5. Cyclic Nucleotide-Gated Channels {#sec3.5}
-------------------------------------

Cyclic nucleotide-gated channels form tetrameric channels which---upon binding of cGMP---allow a flow of cations. For that, these channels track the intracellular concentration of cNMPs to produce a voltage response \[[@B32]\]. Their major role is the depolarization of rod photoreceptors, but they are also found in other tissues like olfactory sensory neurons \[[@B33]\], testis, kidney, or heart \[[@B34]\] and play a role in cellular development such as neuronal growth cone guidance \[[@B35]\]. Defects in these genes are reported to cause retinitis pigmentosa \[[@B36]\]. From 7 used probes one showed a significant upregulation and one showed a significant downregulation (both 14%) during reprogramming, while none was differentially regulated in differentiated neurons or cardiomyocytes.

3.6. GABA Receptors {#sec3.6}
-------------------

GABA (gamma-aminobutyric acid) receptors are ligand-gated chloride channels. Since GABA is the main inhibitory neurotransmitter in the central nervous system GABA receptors play an important role for the brain function. The receptors are composed of five subunits which form heteromers. The GABA receptors are a drug target for anesthetics and other psychoactive drugs. We have analyzed 29 probes within GABA receptor subunits. From keratinocytes to iPSCs, 6 (21%) of them are significantly upregulated while just one (3%) is significantly downregulated. Interestingly, none was up- or downregulated in differentiated neurons, while *GABRB3* was downregulated and *GABRP* was upregulated in cardiomyocytes. Up to now, more or less nothing is known about GABA receptors or their subunits in cardiac cells.

3.7. Glycine Receptors {#sec3.7}
----------------------

Glycine receptors are inhibitory receptors of the postsynaptic site. They are activated by glycine and mediate an influx of chloride ions. Accordingly, GlyRs regulate not only the excitability of motor and sensory neurons but are also essential for the processing of photoreceptor signals, neuronal development, and inflammatory pain sensitization \[[@B37]\]. The heteromeric pore is formed by five subunits. Concerning their role in pathomechanisms, it was reported that mutations are causing hyperekplexia (also known as startle disease) \[[@B38]\]. We have analyzed 7 probes and none of them was significantly altered in hiPSCs. Transcript levels for the alpha2 subunit and the beta subunit were highly upregulated in differentiated neurons, pointing to their functional role in the nervous system.

3.8. Ionotropic Glutamate Receptors {#sec3.8}
-----------------------------------

Glutamate is the predominant excitatory neurotransmitter in the central nervous system. Therefore, ionotropic glutamate receptors play a key role for learning and memory processes. They are located in the postsynaptic membrane and are composed of several heteromeric subunits. Ionotropic glutamate receptors are further divided into AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate), NMDA (N-Methyl-D-aspartate) or kainate receptors depending on their sensitivity for the agonists. From 36 probes, 5 (14%) showed a significantly increased expression and 2 (6%) showed a decreased expression in iPSCs compared to keratinocytes. As expected, several subunits were upregulated in neurons (none downregulated). None was upregulated in cardiomyocytes, while the kainate subtype *GRIK5* was downregulated.

3.9. Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels {#sec3.9}
-----------------------------------------------------------------

Hyperpolarization-activated cyclic nucleotide-gated channels are homodimers or heterodimers and form a hyperpolarization-activated potassium channel. CNG channels display a very complex heteromeric structure with various subunits and domains that play a critical role in their function \[[@B39]\]. They contribute to pacemaker currents in the heart \[[@B40]\] but are also found in neurons \[[@B41]\]. We have analyzed 5 probes and 3 (60%) of them showed a significant upregulation while none was downregulated after reprogramming. In neurons the *HCN3* channel transcript was upregulated, which plays a role in several neuronal functions including excitability of basal ganglia output neurons \[[@B42]\]. Although *HCN4* for example plays a critical role in the conduction system of the heart, we did not observe a specific regulation in cardiomyocytes.

3.10. Serotonin Receptors {#sec3.10}
-------------------------

Serotonin (or 5-hydroxytryptamine) receptors are ligand-gated receptors mainly found presynaptically in neurons. The type 3 receptor is the only ion channel while the other serotonin receptors are G-protein-coupled receptors. It forms a heteropentameric pore which upon activation by serotonin allows the flow of sodium and potassium, leading to a depolarization. Serotonin receptors modulate neuronal function and are therefore involved in various brain functions. The analysis of 6 probes for type 3 serotonin receptors showed a significant upregulation of 2 (33%, both for *HTR3A*) probes while none was downregulated in hiPSCs. Although we expected serotonin receptors to be upregulated during neuronal differentiation, no subunit was upregulated in neurons or cardiomyocytes, while only the receptor transcript for *HTR3A*was downregulated in neurons.

3.11. Voltage-Gated Potassium Channels {#sec3.11}
--------------------------------------

Voltage-gated potassium channels are composed of a large group of subunits with different characteristics concerning for example their inactivation speed. Functional channels are formed by heterotetramers. The channels are highly specific for potassium with a low affinity for sodium or other cations. Voltage-gated potassium channels are responsible for the repolarization of excitable cells following the sodium-mediated excitation of an action potential and are therefore found in neurons and other cells displaying action potentials. We have analyzed 81 probes. From keratinocytes to hiPSCs, 25 (31%) were significantly upregulated while only 3 (4%) were significantly downregulated. In neurons, several subunits were upregulated including *KCNB1*, coding for Kv2.1 and *KCND2*, both are better known for their role in cardiac cell excitability as well as *KCNF1, KCNH8,* and *KCNIP1*, all known for their contribution in neuronal excitability \[[@B43]\]. It should be noted that *KCNT1* is actually sodium activated but is included in the alphabetical list for a better overview. Further, several "S" subunits were upregulated (*KCNS2* in neurons) or downregulated (*KCNS3* in neurons; KCNS1 and 3 in cardiomyocytes). These subunits are unable to form functional channels as homotetramers but instead heterotetramerize with other alpha-subunits to form conductive channels. These subunits are involved in modifying the channels response and conductivity \[[@B44]\]. Few is known about distinct roles in other tissues, but they were associated with for example, pain modulation \[[@B45]\] or airway responsiveness \[[@B46]\].

3.12. Inwardly Rectifying Potassium Channels {#sec3.12}
--------------------------------------------

Inwardly rectifying potassium channels have a higher tendency to allow the flow of potassium ions into the cell rather than to the outside of the cell. Therefore, they play an important role in the maintenance of the resting membrane potential. Their activation is constitutive or controlled by ATP binding and G-proteins \[[@B47]\]. Functional channels are formed as homo- or heterotetramers. These channels can be found predominantly in neurons, cardiac myocytes, the pancreas, or the kidneys. From 20 analyzed probes in hiPSCs compared to keratinocytes, 8 (40%) showed a significant upregulation and 3 (15%) were significantly downregulated. The GIRK2 channel encoded by *KCNJ6* is upregulated in neurons playing multiple roles in various tissues including the pancreas and brain \[[@B48], [@B49]\] and is associated with epileptic seizures in mice lacking the gene \[[@B50]\]. On the other hand, Kir6.1, encoded by *KCNJ8,* is upregulated in cardiomyocytes and has been reported to be involved in the pathogenesis of cardiac arrest in the early repolarization syndrome \[[@B51]\].

3.13. Two-P Potassium Channels {#sec3.13}
------------------------------

Two-P potassium channels contain two pore-forming P domains. After dimerization they form an outward rectifying potassium channel. They can be found in several tissues and are activated by various chemical or physical means (TRAAK channels). We have analyzed 23 probes. 4 (17%) of them were significantly upregulated while 4 (17%) were significantly downregulated. In neurons *KCNK3*, vital for setting the resting membrane potential and primary target for volatile anesthetics \[[@B52]\] as well as *KCNK4,*which is mechanically gated and contributes to axonal pathfinding, growth cone motility, and neurite elongation, as well as possibly having a role in touch or pain detection \[[@B53], [@B54]\], were upregulated. *KCNK5* and 6 were downregulated. In cardiomyocytes, downregulation of *KCNK5* and 12 was observed.

3.14. Calcium-Activated Potassium Channels {#sec3.14}
------------------------------------------

Calcium-activated potassium channels are mostly activated by intracellular calcium; some family members are also voltage gated. The family consists of large, intermediate, and small conductance family members. Channels are formed by two units (*KCNM* family) or most commonly four units (*KCNN* family). They are involved in, for example, afterhyperpolarization following the action potential and are predominantly found in neurons. Additionally, they are known to play different roles in cellular mechanisms, including stem cell biology \[[@B4]--[@B6], [@B55]\]. We have analyzed 18 probes of which 9 (50%) were significantly upregulated and none was significantly downregulated after reprogramming. In neurons, solely *KCNN2* was downregulated, while in cardiomyocytes *KCNMA1*, encoding the large conductance BK-channel, involved in heart rate regulation \[[@B56]\], was upregulated.

3.15. P2X Receptors {#sec3.15}
-------------------

P2X receptors are receptors for extracellular ATP and upon activation open a channel for ions, predominantly calcium. The channel is formed by homo- or heterotrimers. They are found in several tissues, mainly in the nervous system and muscle tissue. They are involved in a range of physiological processes such as modulation of synaptic transmission, vascular tone, cardiac rhythm, and contractility and immune response \[[@B57]--[@B61]\]. In stem cells an influence of P2X receptors on embryonic stem cell proliferation was reported \[[@B62]\]. From the 9 analyzed probes 1 (11%) was significantly upregulated and none downregulated. None of these receptors/channels was regulated in differentiated progeny.

3.16. Transient Receptor Potential Channels {#sec3.16}
-------------------------------------------

Transient receptor potential channels (TRP channels) are nonselective cation channels. They show different preferences for cations, as well as different activation mechanisms and functions. TRP channels are broadly expressed throughout the organism and mediate multiple functions. These include amongst others sensor activity for a wide range of hypertrophic stimuli and mutations in *TRPM4* are now recognized as causes of human cardiac conduction disorders (reviewed in \[[@B63]\]). Furthermore, TRP channels are related to the onset or progression of several diseases, and defects in the genes encoding TRP channels (so-called "TRP channelopathies") underlie certain neurodegenerative disorders due to their abnormal Ca^2+^ signaling properties (reviewed in \[[@B64]\]). Additionally, TRP channels influence stem cell differentiation and survival \[[@B65], [@B66]\] and are involved in neuronal-stem-cell-derived development \[[@B67]\]. We have analyzed 40 probes. After reprogramming, 11 (28%) of them were significantly upregulated and none was significantly downregulated. In neurons, none of these channels was noteworthily regulated while solely *TRPC3* was upregulated in cardiomyocytes, reported to be involved in conduction disturbances induced by adenosine receptor A1AR by enhanced Ca^2+^ entry through the *TRPC3* channel \[[@B68]\].

3.17. Voltage-Gated Sodium Channels {#sec3.17}
-----------------------------------

Voltage-gated sodium channels consist of a main alpha unit and some optional modulating or regulatory subunits. They are highly selective for sodium and are involved in a variety of cellular functions including action potential formation \[[@B69]\]. From 24 probes we have analyzed, 6 (25%) were significantly upregulated and two (8%) were significantly downregulated from keratinocytes to iPS cells. These channels seem to be expressed in different kinds of stem cells and during development \[[@B70]--[@B72]\]. It was further reported that, for example, *SCN5A*, highly upregulated in iPS cells, is involved in cancer stem cell invasion \[[@B73]\]. *SCN2A*, *SCN3A,* and *SCN3B*were upregulated in neurons, described to be involved in neuronal excitation and epilepsy pathogenesis \[[@B74]\]. Although voltage-gated sodium channels play multiple roles also in the cardiac system \[[@B70], [@B75], [@B76]\], we observed no changes of this channel family in cardiomyocytes.

3.18. Nonvoltage-Gated Sodium Channels {#sec3.18}
--------------------------------------

Epithelial nonvoltage-gated sodium channels are amiloride sensitive. They form heterotrimers and are involved in ion and fluid transport across epithelia in several organs. We have analyzed 6 probes and one (17%) of them was significantly upregulated while none was significantly downregulated. Interestingly, the upregulated *SCNN1A* in iPS cells was subsequently downregulated both in neurons and cardiomyocytes, pointing to a possible function in stem cells. Of note, it was shown already that repression of pluripotency by retinoic acid represses the *SCNN1A* gene together with several other pluripotency factors \[[@B77]\].

3.19. Two-Pore Channels {#sec3.19}
-----------------------

Two-pore channels are cation-selective ion channels activated by the second messenger nicotinic acid adenine dinucleotide phosphate (NAADP). Upon activation calcium is released from intracellular stores \[[@B78]\]. We have analyzed 5 probes and while none of them was significantly upregulated two (40%) were significantly downregulated from keratinocytes to iPS cells. None of these channels was regulated in neurons or cardiomyocytes.

3.20. Zinc-Activated Ligand-Gated Ion Channels {#sec3.20}
----------------------------------------------

The zinc-activated ligand-gated ion channel is activated upon binding of zinc. Until now just one family member is known that is expressed in several tissues \[[@B79]\]. Its exact function is not known. The expression was not significantly altered as shown by one probe in all cells.

4. Discussion {#sec4}
=============

Although ion channels are mainly known for their role in electrically excitable cells they can be found in almost all tissues and are additionally involved in various processes such as cell differentiation and maturation \[[@B3], [@B4], [@B6], [@B12], [@B24], [@B47], [@B70]\]. These large groups of channel proteins are still underestimated concerning their role during embryonic development and cell fate determination. One of the most interesting *in vitro* models for the elucidation of both developmental processes and disease-specific cellular impairments is represented by pluripotent stem cells. Therefore we were interested in the set of ion channels expressed in hiPSCs after reprogramming and compared this set with iPSC-derived differentiated progeny, namely, neurons and cardiomyocytes. As little is known about ion channels in hiPSCs we aimed to start the analysis with gene expression microarray data. For a comparison, we chose the cells from which they were produced---namely, keratinocytes---as the reference cell type. The comparison of 6 keratinocyte samples with 9 hiPSC samples should minimize the often observed variances between hiPSC lines. We found out that almost a third (32%) of the ion channel probes we investigated showed a significant change in gene expression. Of note, this was mostly an upregulation. Additionally, while many ion channel genes were not expressed in keratinocytes they were present in hiPSCs. This indicates that several of the analyzed channel groups might play unknown roles in stem cell biology, for example, homeostasis, proliferation, or differentiation. Interestingly, after differentiation into neurons or cardiomyocytes, relatively small groups were subsequently regulated. This includes ion channel transcripts playing important roles in the respective tissues. Nevertheless, we compared already published sets of data from different experimental setups and additionally limited the analysis to a strong fold regulation. This might lead to high dropout rates of regulated genes during measurement. Still, various channel transcripts were "logically" up- or downregulated during differentiation into neurons or cardiomyocytes, following embryonic development. iPS cells and especially patient-specific iPS cells from persons suffering from genetic mutations leading to hereditary syndromes are a very valuable tool to investigate pathogenetic mechanisms and disease associated molecular and cellular changes \[[@B80]--[@B82]\]. As various channel subtypes are involved in multiple pathogenetic mechanisms it would be further interesting to analyze channel transcript regulation in patient specific iPS cells and their differentiated progeny to elucidate possible disease-specific pathways.

Concerning the presented study it is clear that gene regulations on transcript level do not explicitly mimic either protein levels and posttranslational modifications or protein activity. This set of data is sought to describe a global overview on transcript regulation of ion channels during distinct steps of development. It should be noted that in cases where several probes bind within one gene they do not indicate the same upregulation. Sometimes they show the same trend but miss significance, but for some cases there are considerable differences. This could hint for some yet unknown splicing variants. More detailed studies of these hypothesized splice variants could give insights into their function and broaden the still scarce knowledge.

This work is intended to be a guide and start point for future work focusing on single channels and their composition, localization, and function in hiPSCs and their differentiated progeny. These studies could lead to better *in vitro* differentiation protocols but also explain some of the many disease pathomechanisms related to mutations in ion channel genes.
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###### 

The expression levels for ion channel genes were compared in hiPSCs (9 samples) and keratinocytes (6 samples) via microarray. Gene names, accession numbers, and gene symbols are shown together with the corresponding fold change and *P* values. Significant changes (defined as fold change \> 2, *P* \< 0.05) are labeled in bold for upregulation or italic for downregulation. Accession numbers refer to the NCBI or Ensembl (numbers starting with ENST) databases. Analyses of hiPSC-derived neurons or hiPSC-derived cardiomyocytes were performed using published data sets from GSE34879 (neurons) and GSE17579 (cardiomyocytes). These data sets already contain both iPSCs and differentiated progeny. Fold changes \> 2 (marked bold) and \<−2 (marked italic) are shown in the respective columns.

###### 

\(a\) Voltage-gated calcium channels

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                         Accession number   Gene symbol   *P*              Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                                      Ker → hiPSC    hiPSC → Neuron   
  ------------------------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit, transcript variant 1              NM_000068          CACNA1A       2.26*E* − 01     −1.32                            

  Calcium channel, voltage-dependent, N type, alpha 1B subunit                                      NM_000718          CACNA1B       7.27*E* − 01     −1.10                            

  Calcium channel, voltage-dependent, N type, alpha 1B subunit \[Source: HGNC Symbol; Acc: 1389\]   ENST00000277550    CACNA1B       7.15*E* − 01     −1.14                            

  Calcium channel, voltage-dependent, N type, alpha 1B subunit                                      NM_000718          CACNA1B       6.32**E** − 09   **6.82**                         

  Calcium channel, voltage-dependent, N type, alpha 1B subunit \[Source: HGNC Symbol; Acc: 1389\]   ENST00000277551    CACNA1B       3.32*E* − 02     −1.57                            

  Calcium channel, voltage-dependent, L type, alpha 1C subunit, transcript variant 18               NM_000719          CACNA1C       6.77*E* − 02     −1.37                            

  Calcium channel, voltage-dependent, L type, alpha 1C subunit, transcript variant 18               NM_000719          CACNA1C       5.72**E** − 03   **2.37**                        **2.94**

  Calcium channel, voltage-dependent, L type, alpha 1D subunit, transcript variant 1                NM_000720          CACNA1D       3.83*E* − 01     1.58                             

  Calcium channel, voltage-dependent, R type, alpha 1E subunit, transcript variant 3                NM_000721          CACNA1E       *3.10 E*−*02*    *−4.48*        **2.08**          

  Calcium channel, voltage-dependent, R type, alpha 1E subunit \[Source: HGNC Symbol; Acc: 1392\]   ENST00000524607    CACNA1E       8.83*E* − 01     1.05                             

  Calcium channel, voltage-dependent, L type, alpha 1F subunit                                      NM_005183          CACNA1F       8.92*E* − 01     1.02                             

  Calcium channel, voltage-dependent, T type, alpha 1G subunit, transcript variant 15               NM_198397          CACNA1G       6.42*E* − 01     −1.12          **4.60**          

  Calcium channel, voltage-dependent, T type, alpha 1G subunit, transcript variant 1                NM_018896          CACNA1G       5.37**E** − 07   **6.96**                         

  Calcium channel, voltage-dependent, T type, alpha 1H subunit, transcript variant 1                NM_021098          CACNA1H       7.38**E** − 10   **6.78**                         

  Calcium channel, voltage-dependent, T type, alpha 1I subunit, transcript variant 1                NM_021096          CACNA1I       2.22**E** − 11   **37.25**                        

  Calcium channel, voltage-dependent, T type, alpha 1I subunit, transcript variant 1                NM_021096          CACNA1I       7.56*E* − 02     −1.56                            

  Calcium channel, voltage-dependent, L type, alpha 1S subunit                                      NM_000069          CACNA1S       5.22*E* − 02     −1.97                            

  Calcium channel, voltage-dependent, alpha 2/delta subunit 1                                       NM_000722          CACNA2D1      1.38**E** − 09   **9.65**                         

  Calcium channel, voltage-dependent, alpha 2/delta subunit 2, transcript variant 1                 NM_001005505       CACNA2D2      3.30**E** − 10   **62.50**      **2.02**          

  Calcium channel, voltage-dependent, alpha 2/delta subunit 3                                       NM_018398          CACNA2D3      5.14**E** − 05   **5.42**       **2.55**         

  Calcium channel, voltage-dependent, alpha 2/delta subunit 3                                       AF516696           CACNA2D3      4.68**E** − 11   **33.67**                        

  Calcium channel, voltage-dependent, alpha 2/delta subunit 4                                       NM_172364          CACNA2D4      2.95*E* − 01     −1.41                            

  Calcium channel, voltage-dependent, beta 1 subunit, transcript variant 3                          NM_199248          CACNB1        4.31*E* − 01     −1.14                            

  Calcium channel, voltage-dependent, beta 1 subunit, transcript variant 1                          NM_000723          CACNB1        8.02*E* − 01     −1.02                            

  Calcium channel, voltage-dependent, beta 1 subunit, transcript variant 1                          NM_000723          CACNB1        6.22*E* − 01     1.04                             

  cDNA FLJ45229 fis, clone BRCAN2020972,                                                            AK128769           CACNB2        9.78*E* − 01     1.02                             

  Calcium channel, voltage-dependent, beta 2 subunit, transcript variant 1                          NM_000724          CACNB2        4.71**E** − 02   **3.45**                         

  Calcium channel, voltage-dependent, beta 3 subunit, transcript variant 1                          NM_000725          CACNB3        3.55*E* − 02     −1.93          **9.56**          

  Calcium channel, voltage-dependent, beta 3 subunit, transcript variant 1                          NM_000725          CACNB3        6.61*E* − 01     1.09                             

  Calcium channel, voltage-dependent, beta 4 subunit, transcript variant 1                          NM_001005747       CACNB4        1.33**E** − 03   **4.43**                         

  Calcium channel, voltage-dependent, gamma subunit 1                                               NM_000727          CACNG1        9.46*E* − 01     1.02                             

  Calcium channel, voltage-dependent, gamma subunit 2                                               NM_006078          CACNG2        4.19*E* − 01     −1.29                            

  Calcium channel, voltage-dependent, gamma subunit 2                                               NM_006078          CACNG2        7.91*E* − 01     1.09                             

  Calcium channel, voltage-dependent, gamma subunit 3                                               NM_006539          CACNG3        2.21*E* − 01     −1.95                            

  Calcium channel, voltage-dependent, gamma subunit 4                                               NM_014405          CACNG4        4.93*E* − 01     1.14                             

  Calcium channel, voltage-dependent, gamma subunit 5                                               NM_145811          CACNG5        7.49*E* − 01     −1.13                            

  Calcium channel, voltage-dependent, gamma subunit 5 \[Source: HGNC Symbol; Acc: 1409\]            ENST00000169565    CACNG5        2.19*E* − 01     −1.56                            

  Calcium channel, voltage-dependent, gamma subunit 6, transcript variant 1                         NM_145814          CACNG6        5.56**E** − 11   **46.40**                        

  Calcium channel, voltage-dependent, gamma subunit 7                                               NM_031896          CACNG7        3.54**E** − 13   **1439.36**    **3.37**          

  Calcium channel, voltage-dependent, gamma subunit 7                                               NM_031896          CACNG7        1.82*E* − 01     1.26                             

  Calcium channel, voltage-dependent, gamma subunit 8                                               NM_031895          CACNG8        2.01*E* − 01     1.43                             

  Calcium channel, voltage-dependent, gamma subunit 8                                               NM_031895          CACNG8        1.18**E** − 09   **9.70**                         
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(b\) Sperm-associated cation channels

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                  Accession number   Gene symbol   P               Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                              Ker → hiPSC    hiPSC → Neuron   
  ---------------------------------------------------------- ------------------ ------------- --------------- -------------- ---------------- ------------------------
  Cation channel, sperm associated 1                         NM_053054          CATSPER1      3.26*E* − 01    1.51                             

  Cation channel, sperm associated 2, transcript variant 2   NM_172095          CATSPER2      *1.32 E*−*04*   *−2.78*                         

  Cation channel, sperm associated 2, transcript variant 4   NM_172097          CATSPER2      3.12*E* − 02    −1.78                            

  Cation channel, sperm associated 3                         NM_178019          CATSPER3      1.50*E* − 03    1.93                             

  Cation channel, sperm associated 4                         NM_198137          CATSPER4      2.51*E* − 01    1.48                             

  Cation channel, sperm-associated, beta                     NM_024764          CATSPERB      4.38*E* − 01    −1.25                            

  Cation channel, sperm-associated, gamma                    NM_021185          CATSPERG      3.56*E* − 01    1.34                             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(c\) Nicotinic acetylcholine receptors

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                                       Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                                                    Ker → hiPSC    hiPSC → Neuron   
  --------------------------------------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Cholinergic receptor, nicotinic, alpha 1 (muscle), transcript variant 1                                         NM_001039523       CHRNA1        8.06*E* − 01     −1.10                            

  Cholinergic receptor, nicotinic, alpha 1 (muscle), (cDNA clone IMAGE: 4124038), with apparent retained intron   BC006314           CHRNA1        4.64*E* − 01     1.47                             

  Cholinergic receptor, nicotinic, alpha 2 (neuronal)                                                             NM_000742          CHRNA2        6.05*E* − 01     −1.30                            

  Cholinergic receptor, nicotinic, alpha 3, transcript variant 1                                                  NM_000743          CHRNA3        1.84**E** − 10   **34.22**                        

  Cholinergic receptor, nicotinic, alpha 4                                                                        NM_000744          CHRNA4        6.79*E* − 01     1.15                             

  Cholinergic receptor, nicotinic, alpha 4 (neuronal), exon 1                                                     X89741             CHRNA4        *2.79 E*−*02*    *−2.53*                          

  Cholinergic receptor, nicotinic, alpha 5                                                                        NM_000745          CHRNA5        4.03**E** − 05   **3.41**                         

  Cholinergic receptor, nicotinic, alpha 6, transcript variant 1                                                  NM_004198          CHRNA6        2.23*E* − 01     −1.27          **2.21**          

  Cholinergic receptor, nicotinic, alpha 7, transcript variant 1                                                  NM_000746          CHRNA7        4.61*E* − 04     1.86                             

  Cholinergic receptor, nicotinic, alpha 7, transcript variant 2                                                  NM_001190455       CHRNA7        1.56*E* − 11     13.24                            

  Cholinergic receptor, nicotinic, alpha 9                                                                        NM_017581          CHRNA9        6.30**E** − 06   **6.15**                         

  Cholinergic receptor, nicotinic, alpha 10                                                                       NM_020402          CHRNA10       1.57*E* − 02     1.57                             

  Cholinergic receptor, nicotinic, beta 1 (muscle)                                                                NM_000747          CHRNB1        *8.07 E*−*04*    *−2.47*                          

  Cholinergic receptor, nicotinic, beta 1 (muscle)                                                                NM_000747          CHRNB1        8.87*E* − 03     −1.92                            

  Cholinergic receptor, nicotinic, beta 2 (neuronal)                                                              NM_000748          CHRNB2        *6.03 E*−*04*    *−3.01*                          

  Cholinergic receptor, nicotinic, beta 2 (neuronal) \[Source: HGNC Symbol; Acc: 1962\]                           ENST00000368476    CHRNB2        2.98**E** − 09   **32.05**                        

  Cholinergic receptor, nicotinic, beta 3                                                                         NM_000749          CHRNB3        5.91*E* − 01     1.12                             

  Cholinergic receptor, nicotinic, beta 4                                                                         NM_000750          CHRNB4        1.76**E** − 02   **4.20**                         

  Cholinergic receptor, nicotinic, delta                                                                          NM_000751          CHRND         9.84*E* − 01     1.01                             

  Cholinergic receptor, nicotinic, epsilon                                                                        NM_000080          CHRNE         3.66*E* − 01     −1.20                            

  Cholinergic receptor, nicotinic, gamma                                                                          NM_005199          CHRNG         6.70*E* − 01     1.14                             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(d\) Cyclic nucleotide-gated channels

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                       Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                    Ker → hiPSC    hiPSC → Neuron   
  --------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Cyclic nucleotide-gated channel alpha 1, transcript variant 2   NM_000087          CNGA1         7.14*E* − 01     1.15                            

  Cyclic nucleotide-gated channel alpha 1, transcript variant 2   NM_000087          CNGA1         1.18**E** − 02   2.00                             

  Cyclic nucleotide-gated channel alpha 3, transcript variant 1   NM_001298          CNGA3         2.00*E* − 01     1.21                             

  Cyclic nucleotide-gated channel alpha 4                         NM_001037329       CNGA4         2.78*E* − 01     1.82                             

  Cyclic nucleotide-gated channel beta 1, transcript variant 1    NM_001297          CNGB1         *9.22 E*−*03*    *−2.05*                          

  Cyclic nucleotide-gated channel beta 1, transcript variant 1    NM_001297          CNGB1         6.36*E* − 01     −1.13                            

  Cyclic nucleotide-gated channel beta 3                          NM_019098          CNGB3         2.93*E* − 01     1.78                             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(e\) GABA receptors

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                            Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                         Ker → hiPSC    hiPSC → Neuron   
  ------------------------------------------------------------------------------------ ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Gamma-aminobutyric acid (GABA) A receptor, alpha 1, transcript variant 1             NM_000806          GABRA1        1.26*E* − 01     1.41                             

  Gamma-aminobutyric acid (GABA) A receptor, alpha 1, transcript variant 1             NM_000806          GABRA1        8.87*E* − 01     1.05                             

  Gamma-aminobutyric acid (GABA) A receptor, alpha 2, transcript variant 1             NM_000807          GABRA2        9.70*E* − 02     1.70                             

  Gamma-aminobutyric acid (GABA) A receptor, alpha 2, transcript variant 1             NM_000807          GABRA2        4.49*E* − 01     1.48                             

  Gamma-aminobutyric acid (GABA) A receptor, alpha 3                                   NM_000808          GABRA3        2.10*E* − 01     1.43                             

  Gamma-aminobutyric acid (GABA) A receptor, alpha 4, transcript variant 1             NM_000809          GABRA4        3.76*E* − 01     1.43                             

  Gamma-aminobutyric acid (GABA) A receptor, alpha 4, transcript variant 1             NM_000809          GABRA4        8.30*E* − 01     1.05                             

  Gamma-aminobutyric acid (GABA) A receptor, alpha 5, transcript variant 1             NM_000810          GABRA5        1.09**E** − 08   **14.41**                        

  Gamma-aminobutyric acid (GABA) A receptor, alpha 6                                   NM_000811          GABRA6        1.69*E* − 01     1.23                             

  Gamma-aminobutyric acid (GABA) A receptor, beta 1                                    NM_000812          GABRB1        1.14*E* − 01     1.43                             

  Gamma-aminobutyric acid (GABA) A receptor, beta 2, transcript variant 2              NM_000813          GABRB2        1.27*E* − 02     1.94                             

  Gamma-aminobutyric acid (GABA) A receptor, beta 3, transcript variant 1              NM_000814          GABRB3        6.70**E** − 10   **85.93**                       *−4.49*

  Gamma-aminobutyric acid (GABA) A receptor, beta 3, transcript variant 1              NM_000814          GABRB3        1.15**E** − 09   **115.69**                       

  Gamma-aminobutyric acid (GABA) A receptor, delta                                     NM_000815          GABRD         6.26*E* − 02     3.02                             

  Gamma-aminobutyric acid (GABA) A receptor, epsilon                                   NM_004961          GABRE         *5.83 E*−*05*    *−5.47*                          

  Gamma-aminobutyric acid (GABA) A receptor, Gamma 1                                   NM_173536          GABRG1        1.78*E* − 01     1.24                             

  Gamma-aminobutyric acid (GABA) A receptor, Gamma 1                                   NM_173536          GABRG1        1.70**E** − 02   **2.19**                         

  Gamma-aminobutyric acid (GABA) A receptor, Gamma 2, transcript variant 1             NM_198904          GABRG2        6.02*E* − 01     1.14                            

  Gamma-aminobutyric acid (GABA) A receptor, Gamma 2, transcript variant 2             NM_000816          GABRG2        5.28*E* − 02     1.72                             

  Gamma-aminobutyric acid (GABA) A receptor, Gamma 2, transcript variant 2             NM_000816          GABRG2        9.47**E** − 09   **8.41**                         

  Gamma-aminobutyric acid (GABA) A receptor, Gamma 3                                   NM_033223          GABRG3        1.99*E* − 01     2.00                             

  Gamma-aminobutyric acid (GABA) A receptor, Gamma 3                                   NM_033223          GABRG3        1.04*E* − 01     1.61                             

  Gamma-aminobutyric acid (GABA) A receptor, pi                                        NM_014211          GABRP         6.62*E* − 01     −1.12                           **17.25**

  Gamma-aminobutyric acid (GABA) receptor, theta                                       NM_018558          GABRQ         1.60*E* − 01     1.56                             

  Gamma-aminobutyric acid (GABA) receptor, theta                                       NM_018558          GABRQ         4.76*E* − 01     −1.27                            

  Gamma-aminobutyric acid (GABA) receptor, theta \[Source: HGNC Symbol; Acc: 14454\]   ENST00000370306    GABRQ         8.22**E** − 09   **52.17**                        

  Gamma-aminobutyric acid (GABA) receptor, rho 1                                       NM_002042          GABRR1        8.94*E* − 01     −1.04                            

  Gamma-aminobutyric acid (GABA) receptor, rho 2                                       NM_002043          GABRR2        2.83*E* − 01     1.54                             

  Gamma-aminobutyric acid (GABA) receptor, rho 3                                       NM_001105580       GABRR3        3.05*E* − 01     −1.34                            
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(f\) Glycine receptors

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                      Accession number   Gene symbol   P              Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                 Ker → hiPSC    hiPSC → Neuron   
  -------------------------------------------------------------- ------------------ ------------- -------------- -------------- ---------------- ------------------------
  Glycine receptor, alpha 1, transcript variant 2                NM_000171          GLRA1         5.47*E* − 01   −1.29                            

  Glycine receptor, alpha 2, transcript variant 1                NM_002063          GLRA2         1.17*E* − 01   1.42           **11.41**         

  Glycine receptor, alpha 3, transcript variant 1                NM_006529          GLRA3         5.16*E* − 01   −1.26                            

  Glycine receptor, alpha 3 \[Source: HGNC Symbol; Acc: 4328\]   ENST00000274093    GLRA3         8.33*E* − 02   1.64                             

  Glycine receptor, alpha 3, transcript variant 1                NM_006529          GLRA3         1.46*E* − 01   1.41                             

  Glycine receptor, alpha 4, transcript variant 1                NM_001024452       GLRA4         7.75*E* − 01   1.17                             

  Glycine receptor, beta, transcript variant 1                   NM_000824          GLRB          6.38*E* − 02   −1.69          **6.61**          
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(g\) Ionotropic glutamate receptors

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                                             Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                                                          Ker → hiPSC    hiPSC → Neuron   
  --------------------------------------------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Glutamate receptor, ionotropic, AMPA 1, transcript variant 1                                                          NM_000827          GRIA1         7.65*E* − 01     −1.20          **2.06**          

  Glutamate receptor, ionotropic, AMPA 2, transcript variant 1                                                          NM_000826          GRIA2         2.87*E* − 01     −1.87          **21.26**         

  Glutamate receptor, ionotropic, AMPA 2, transcript variant 1                                                          NM_000826          GRIA2         2.72*E* − 01     1.33                             

  Glutamate receptor, ionotropic, AMPA 2, transcript variant 1                                                          NM_000826          GRIA2         6.54*E* − 01     1.22                            

  Glutamate receptor, ionotropic, AMPA 3, transcript variant 2                                                          NM_000828          GRIA3         5.05*E* − 01     1.26                             

  Glutamate receptor, ionotropic, AMPA 3 \[Source: HGNC Symbol; Acc: 4573\]                                             ENST00000371264    GRIA3         1.14*E* − 01     1.50                             

  Glutamate receptor, ionotropic, AMPA 3, transcript variant 2                                                          NM_000828          GRIA3         9.05*E* − 01     −1.05                            

  Glutamate receptor, ionotropic, AMPA 4, transcript variant 1                                                          NM_000829          GRIA4         2.30*E* − 02     1.80           **3.73**          

  Glutamate receptor, ionotropic, delta 1                                                                               NM_017551          GRID1         1.82*E* − 01     1.50                             

  Glutamate receptor, ionotropic, delta 1                                                                               NM_017551          GRID1         5.08**E** − 05   **3.63**                         

  Glutamate receptor, ionotropic, delta 2                                                                               NM_001510          GRID2         7.64*E* − 01     −1.11                            

  Glutamate receptor, ionotropic, delta 2                                                                               NM_001510          GRID2         5.55**E** − 09   **55.66**                        

  Glutamate receptor, ionotropic, kainate 1, transcript variant 1                                                       NM_000830          GRIK1         1.64*E* − 01     1.29           **2.58**          

  Glutamate receptor, ionotropic, kainate 2, transcript variant 3                                                       NM_001166247       GRIK2         1.42*E* − 01     1.56           **2.53**          

  Glutamate receptor, ionotropic, kainate 2, transcript variant 1                                                       NM_021956          GRIK2         1.14*E* − 01     −2.01                            

  Glutamate receptor, ionotropic, kainate 2, transcript variant 2                                                       NM_175768          GRIK2         7.80*E* − 01     1.08                             

  Glutamate receptor, ionotropic, kainate 3                                                                             NM_000831          GRIK3         1.58*E* − 01     1.64                             

  Glutamate receptor, ionotropic, kainate 3                                                                             NM_000831          GRIK3         6.15**E** − 10   **22.64**                        

  Glutamate receptor, ionotropic, kainate 4 \[Source: HGNC Symbol; Acc: 4582\]                                          ENST00000527524    GRIK4         1.77**E** − 11   **18.10**                        

  Glutamate receptor, ionotropic, kainate 4                                                                             NM_014619          GRIK4         5.73*E* − 02     2.54                             

  Glutamate receptor, ionotropic, kainate 5                                                                             NM_002088          GRIK5         2.65*E* − 03     1.79                            *−2.41*

  Glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant NR1-3                                      NM_007327          GRIN1         *1.93 E*−*02*    *−3.02*        **2.69**          

  Glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant NR1-3                                      NM_007327          GRIN1         6.01*E* − 02     −2.45                            

  Glutamate receptor, ionotropic, N-methyl D-aspartate 1, transcript variant NR1-3                                      NM_007327          GRIN1         3.86*E* − 01     −1.65                            

  Glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2                                         NM_000833          GRIN2A        6.54*E* − 01     1.18                             

  Glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2                                         NM_000833          GRIN2A        9.21*E* − 01     −1.02                            

  Glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 1                                         NM_001134407       GRIN2A        3.32**E** − 10   **29.85**                        

  Glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2                                         NM_000833          GRIN2A        2.63*E* − 01     1.55                             

  Glutamate receptor, ionotropic, N-methyl D-aspartate 2B                                                               NM_000834          GRIN2B        6.64*E* − 01     −1.26                            

  Glutamate receptor, ionotropic, N-methyl D-aspartate 2C                                                               NM_000835          GRIN2C        8.01*E* − 01     −1.08                            

  Glutamate receptor, ionotropic, N-methyl D-aspartate 2C                                                               NM_000835          GRIN2C        5.01*E* − 01     1.13                             

  Glutamate receptor, ionotropic, N-methyl D-aspartate 2D                                                               NM_000836          GRIN2D        4.69*E* − 02     −1.82                            

  Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A                                                               NM_133445          GRIN3A        3.28*E* − 01     −1.41                           

  Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B                                                               NM_138690          GRIN3B        9.36*E* − 01     −1.02                            

  Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding), transcript variant 1   NM_000837          GRINA         *3.68 E*−*04*    *−2.05*        **2.05**          

  NMDA receptor glutamate-binding chain (hnrgw), partial                                                                U44954             GRINA         3.06*E* − 04     −1.81                            
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(h\) Hyperpolarization-activated cyclic nucleotide-gated channels

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                 Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                              Ker → hiPSC    hiPSC → Neuron   
  ------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1   NM_021072          HCN1          3.47**E** − 11   **52.85**                        

  Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1   NM_021072          HCN1          1.01**E** − 08   **9.91**                         

  Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2   NM_001194          HCN2          5.36*E* − 02     −1.63                            

  Hyperpolarization-activated cyclic nucleotide-gated potassium channel 3   NM_020897          HCN3          1.98**E** − 02   **2.12**       **6.56**          

  Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4   NM_005477          HCN4          1.01*E* − 01     −1.66                            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(i\) Serotonin receptors

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                          Accession number   Gene symbol   *P*              Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                       Ker → hiPSC    hiPSC → Neuron   
  ---------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  5-hydroxytryptamine (serotonin) receptor 3A, transcript variant 1                  NM_213621          HTR3A         1.99**E** − 03   **2.77**       *−2.20*           

  5-hydroxytryptamine (serotonin) receptor 3A, transcript variant 1                  NM_213621          HTR3A         2.63**E** − 11   **11.11**                        

  5-hydroxytryptamine (serotonin) receptor 3B                                        NM_006028          HTR3B         1.99*E* − 01     −1.54                            

  5-hydroxytryptamine (serotonin) receptor 3, family member C                        NM_130770          HTR3C         4.81*E* − 01     1.34                             

  5-hydroxytryptamine (serotonin) receptor 3 family member D, transcript variant 2   NM_182537          HTR3D         4.75*E* − 01     −1.37                            

  5-hydroxytryptamine (serotonin) receptor 3, family member E                        NM_182589          HTR3E         1.52*E* − 01     −1.44                            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(j\) Voltage-gated potassium channels

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                                     Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                                                  Ker → hiPSC    hiPSC → Neuron   
  ------------------------------------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)           NM_000217          KCNA1         1.64*E* − 01     2.00                             

  Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)           NM_000217          KCNA1         1.31*E* − 01     1.87                             

  Potassium voltage-gated channel, shaker-related subfamily, member 2, transcript variant 2                     NM_001204269       KCNA2         8.55*E* − 02     1.33                            

  Potassium voltage-gated channel, shaker-related subfamily, member 2, transcript variant 1                     NM_004974          KCNA2         8.33*E* − 01     1.06                             

  Potassium voltage-gated channel, shaker-related subfamily, member 3                                           NM_002232          KCNA3         2.43*E* − 01     1.76                             

  Potassium voltage-gated channel, shaker-related subfamily, member 4                                           NM_002233          KCNA4         5.75*E* − 01     1.11                             

  Potassium voltage-gated channel, shaker-related subfamily, member 5                                           NM_002234          KCNA5         1.76**E** − 04   **4.11**                        **5.63**

  Potassium voltage-gated channel, shaker-related subfamily, member 6                                           NM_002235          KCNA6         7.20*E* − 02     2.28                             

  Potassium voltage-gated channel, shaker-related subfamily, member 7                                           NM_031886          KCNA7         8.53**E** − 03   **3.67**                         

  Potassium voltage-gated channel, shaker-related subfamily, member 7                                           NM_031886          KCNA7         1.04*E* − 01     2.39                             

  Potassium voltage-gated channel, shaker-related subfamily, member 10                                          NM_005549          KCNA10        3.32*E* − 01     −1.62                            

  Potassium voltage-gated channel, shaker-related subfamily, beta member 1, transcript variant 2                NM_003471          KCNAB1        2.70*E* − 01     1.46                             

  Potassium voltage-gated channel, shaker-related subfamily, beta member 1, transcript variant 2                NM_003471          KCNAB1        3.60**E** − 02   **2.42**                         

  Potassium voltage-gated channel, shaker-related subfamily, beta member 1, transcript variant 2                NM_003471          KCNAB1        7.87*E* − 02     3.06                             

  Potassium voltage-gated channel, shaker-related subfamily, beta member 2, transcript variant 1                NM_003636          KCNAB2        5.35*E* − 01     −1.35                            

  Potassium voltage-gated channel, shaker-related subfamily, beta member 2, transcript variant 1                NM_003636          KCNAB2        2.20*E* − 01     1.26                             

  Potassium voltage-gated channel, shaker-related subfamily, beta member 3 \[Source: HGNC Symbol; Acc: 6230\]   ENST00000303790    KCNAB3        8.14*E* − 02     1.62                             

  Potassium voltage-gated channel, shaker-related subfamily, beta member 3                                      NM_004732          KCNAB3        3.66*E* − 01     1.35                             

  Potassium voltage-gated channel, Shab-related subfamily, member 1                                             NM_004975          KCNB1         7.42**E** − 08   **16.32**      **2.59**          

  Potassium voltage-gated channel, Shab-related subfamily, member 2                                             NM_004770          KCNB2         1.54**E** − 05   **4.58**                         

  Potassium voltage-gated channel, Shaw-related subfamily, member 1, transcript variant A                       NM_001112741       KCNC1         1.47*E* − 01     1.75                             

  Potassium voltage-gated channel, Shaw-related subfamily, member 1, transcript variant B                       NM_004976          KCNC1         4.86**E** − 08   **13.97**                        

  Potassium voltage-gated channel, Shaw-related subfamily, member 1, transcript variant A                       NM_001112741       KCNC1         2.17*E* − 01     1.56                             

  Potassium voltage-gated channel, Shaw-related subfamily, member 2, transcript variant 1                       NM_139136          KCNC2         8.53*E* − 01     1.06                             

  Potassium voltage-gated channel, Shaw-related subfamily, member 2, transcript variant 2                       NM_139137          KCNC2         4.04*E* − 01     1.34                             

  Potassium voltage-gated channel, Shaw-related subfamily, member 3                                             NM_004977          KCNC3         3.56*E* − 01     1.20                             

  Potassium voltage-gated channel, Shaw-related subfamily, member 4, transcript variant 3                       NM_001039574       KCNC4         7.70*E* − 02     −1.40                            

  Potassium voltage-gated channel, Shal-related subfamily, member 1                                             NM_004979          KCND1         1.48**E** − 04   **7.11**                         

  Potassium voltage-gated channel, Shal-related subfamily, member 2                                             NM_012281          KCND2         1.62**E** − 12   **91.08**      **2.76**         *−2.57*

  Potassium voltage-gated channel, Shal-related subfamily, member 2                                             NM_012281          KCND2         2.76**E** − 09   **21.83**                        

  Potassium voltage-gated channel, Shal-related subfamily, member 3 \[Source: HGNC Symbol; Acc: 6239\]          ENST00000369697    KCND3         5.36*E* − 01     −1.36                            

  Potassium voltage-gated channel, Shal-related subfamily, member 3, transcript variant 1                       NM_004980          KCND3         1.05*E* − 01     1.55                             

  Potassium voltage-gated channel, Shal-related subfamily, member 3, transcript variant 1                       NM_004980          KCND3         4.41*E* − 01     1.37                             

  Potassium voltage-gated channel, Shal-related subfamily, member 3 \[Source: HGNC Symbol; Acc: 6239\]          ENST00000369697    KCND3         3.86*E* − 04     −1.84                            

  Potassium voltage-gated channel, Isk-related family, member 1, transcript variant 2                           NM_000219          KCNE1         3.53*E* − 01     −1.45                            

  Potassium voltage-gated channel, Isk-related family, member 1, transcript variant 2                           NM_000219          KCNE1         3.59*E* − 01     1.25                             

  KCNE1-like                                                                                                    NM_012282          KCNE1L        1.34**E** − 08   **4.44**                        *−2.18*

  KCNE1-like                                                                                                    NM_012282          KCNE1L        1.11**E** − 08   **3.65**                         

  KCNE1-like                                                                                                    NM_012282          KCNE1L        6.41*E* − 03     1.88                             

  Potassium voltage-gated channel, Isk-related family, member 2                                                 NM_172201          KCNE2         1.41**E** − 04   **3.93**                         

  Potassium voltage-gated channel, Isk-related family, member 3                                                 NM_005472          KCNE3         8.65**E** − 15   **52.36**                        

  Potassium voltage-gated channel, Isk-related family, member 4                                                 NM_080671          KCNE4         5.04*E* − 01     1.20                             

  Potassium voltage-gated channel, subfamily F, member 1                                                        NM_002236          KCNF1         2.25**E** − 05   **6.48**       **2.84**          

  Potassium voltage-gated channel, subfamily G, member 1                                                        NM_002237          KCNG1         8.51*E* − 03     −1.82                            

  Potassium voltage-gated channel, subfamily G, member 1                                                        NM_002237          KCNG1         1.55*E* − 01     −1.65                            

  Potassium voltage-gated channel, subfamily G, member 2                                                        NM_012283          KCNG2         6.21*E* − 02     1.32                             

  Potassium voltage-gated channel, subfamily G, member 3, transcript variant 1                                  NM_133329          KCNG3         3.74**E** − 11   **58.95**                       *−2.93*

  Potassium voltage-gated channel, subfamily G, member 4                                                        NM_172347          KCNG4         *3.36 E*−*03*    *−3.33*                          

  Potassium voltage-gated channel, subfamily G, member 4, (cDNA clone IMAGE: 3028985)                           BC008969           KCNG4         *2.24 E*−*04*    *−3.29*                          

  Potassium voltage-gated channel, subfamily H (eag-related), member 1, transcript variant 1                    NM_172362          KCNH1         8.05*E* − 01     −1.15                            

  Potassium voltage-gated channel, subfamily H (eag-related), member 2, transcript variant 1                    NM_000238          KCNH2         5.94**E** − 04   **37.53**                        

  Potassium voltage-gated channel, subfamily H (eag-related), member 2, transcript variant 2                    NM_172056          KCNH2         5.70*E* − 03     1.73                             

  Potassium voltage-gated channel, subfamily H (eag-related), member 3                                          NM_012284          KCNH3         9.65*E* − 01     1.01                             

  Potassium voltage-gated channel, subfamily H (eag-related), member 4                                          NM_012285          KCNH4         3.18*E* − 01     −1.24                           

  Potassium voltage-gated channel, subfamily H (eag-related), member 5, transcript variant 2                    NM_172376          KCNH5         3.04**E** − 03   **2.96**                         

  Potassium voltage-gated channel, subfamily H (eag-related), member 5, transcript variant 1                    NM_139318          KCNH5         5.41*E* − 01     1.47                             

  Potassium voltage-gated channel, subfamily H (eag-related), member 6, transcript variant 2                    NM_173092          KCNH6         2.93**E** − 02   **3.04**                         

  cDNA FLJ33650 fis, clone BRAMY2024514, highly similar to Rattus norvegicus Potassium channel (erg2)           AK090969           KCNH6         2.08**E** − 05   **12.42**                        

  Potassium voltage-gated channel, subfamily H (eag-related), member 6, transcript variant 2                    NM_173092          KCNH6         2.55**E** − 02   **2.29**                         

  Potassium voltage-gated channel, subfamily H (eag-related), member 7, transcript variant 2                    NM_173162          KCNH7         4.63*E* − 01     −1.40                            

  Potassium voltage-gated channel, subfamily H (eag-related), member 7, transcript variant 1                    NM_033272          KCNH7         7.58*E* − 01     −1.09                            

  Potassium voltage-gated channel, subfamily H (eag-related), member 8                                          NM_144633          KCNH8         3.00**E** − 09   **24.57**      **2.97**          

  Kv channel interacting protein 1, transcript variant 1                                                        NM_001034837       KCNIP1        8.33*E* − 02     1.96           **4.24**          

  Kv channel interacting protein 2, transcript variant 7                                                        NM_173197          KCNIP2        6.43*E* − 01     1.21                             

  Kv channel interacting protein 2, transcript variant 1                                                        NM_014591          KCNIP2        2.53*E* − 03     1.96                             

  Kv channel interacting protein 3, calsenilin, transcript variant 1                                            NM_013434          KCNIP3        *1.15 E*−*03*    *−3.47*                          

  Kv channel interacting protein 4, transcript variant 5                                                        NM_001035003       KCNIP4        6.73*E* − 01     1.16                            **2.01**

  Kv channel interacting protein 4, transcript variant 5                                                        NM_001035003       KCNIP4        9.26*E* − 01     1.05                             

  Potassium voltage-gated channel, KQT-like subfamily, member 1, transcript variant 1                           NM_000218          KCNQ1         3.31**E** − 09   **79.52**                        

  Potassium voltage-gated channel, KQT-like subfamily, member 2, transcript variant 5                           NM_172109          KCNQ2         5.68**E** − 19   **3408.43**                      

  Potassium voltage-gated channel, KQT-like subfamily, member 2, transcript variant 3                           NM_004518          KCNQ2         1.29*E* − 02     1.82                             

  Potassium voltage-gated channel, KQT-like subfamily, member 2, (cDNA clone IMAGE: 4154700)                    BC020384           KCNQ2         1.09**E** − 08   **37.12**                        

  Potassium voltage-gated channel, KQT-like subfamily, member 3, transcript variant 1                           NM_004519          KCNQ3         1.10*E* − 04     −1.69                            

  Potassium voltage-gated channel, KQT-like subfamily, member 4, transcript variant 1                           NM_004700          KCNQ4         9.77*E* − 01     1.02                             

  Potassium voltage-gated channel, KQT-like subfamily, member 5, transcript variant 1                           NM_019842          KCNQ5         9.81*E* − 02     −1.79                            

  Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1                                     NM_002251          KCNS1         3.39*E* − 01     −1.27                           *−2.64*

  Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2                                     NM_020697          KCNS2         6.19*E* − 02     −2.45          **2.11**          

  Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3                                     NM_002252          KCNS3         1.04**E** − 04   **2.22**       *−2.61*          *−2.39*

  Potassium channel, subfamily T, member 1 (sodium activated)                                                   NM_020822          KCNT1         8.51*E* − 02     −2.17                           

  Potassium channel, subfamily V, member 1                                                                      NM_014379          KCNV1         7.84*E* − 02     1.58                             

  Potassium channel, subfamily V, member 2                                                                      NM_133497          KCNV2         7.63*E* − 01     −1.16                            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(k\) Inwardly rectifying potassium channels

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                         Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                                      Ker → hiPSC    hiPSC → Neuron   
  ------------------------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Potassium inwardly-rectifying channel, subfamily J, member 1, transcript variant rom-k5           NM_153767          KCNJ1         2.54**E** − 02   **2.66**                         

  Potassium inwardly-rectifying channel, subfamily J, member 1, transcript variant rom-k5           NM_153767          KCNJ1         8.51*E* − 01     −1.05                            

  Potassium inwardly-rectifying channel, subfamily J, member 2                                      NM_000891          KCNJ2         5.14**E** − 04   **4.38**                         

  Potassium inwardly-rectifying channel, subfamily J, member 3                                      NM_002239          KCNJ3         4.56*E* − 01     1.34                             

  Potassium inwardly-rectifying channel, subfamily J, member 4, transcript variant 1                NM_152868          KCNJ4         4.80**E** − 02   **2.30**                         

  Potassium inwardly-rectifying channel, subfamily J, member 5                                      NM_000890          KCNJ5         *1.88 E*−*08*    *−45.40*                         

  Potassium inwardly-rectifying channel, subfamily J, member 5                                      NM_000890          KCNJ5         *4.42 E*−*12*    *−109.11*                        

  Potassium inwardly-rectifying channel, subfamily J, member 6                                      NM_002240          KCNJ6         3.29**E** − 05   **6.75**       **5.54**          

  Potassium inwardly-rectifying channel, subfamily J, member 8                                      NM_004982          KCNJ8         1.98**E** − 04   **5.97**                        **2.74**

  Potassium inwardly-rectifying channel, subfamily J, member 9 \[Source: HGNC Symbol; Acc: 6270\]   ENST00000368088    KCNJ9         3.17*E* − 01     1.49                             

  Potassium inwardly-rectifying channel, subfamily J, member 9                                      NM_004983          KCNJ9         3.07*E* − 01     1.79                             

  Potassium inwardly-rectifying channel, subfamily J, member 10                                     NM_002241          KCNJ10        8.85**E** − 04   **4.14**                         

  Potassium inwardly-rectifying channel, subfamily J, member 10                                     NM_002241          KCNJ10        9.56*E* − 01     1.01                             

  Potassium inwardly-rectifying channel, subfamily J, member 11, transcript variant 1               NM_000525          KCNJ11        4.00**E** − 04   **2.93**                         

  Potassium inwardly-rectifying channel, subfamily J, member 12                                     NM_021012          KCNJ12        1.00*E* − 01     1.47                             

  Potassium inwardly-rectifying channel, subfamily J, member 12                                     NM_021012          KCNJ12        3.53**E** − 06   **5.81**                         

  Potassium inwardly-rectifying channel, subfamily J, member 13, transcript variant 1               NM_002242          KCNJ13        7.75*E* − 01     1.20                             

  Potassium inwardly-rectifying channel, subfamily J, member 14, transcript variant 2               NM_170720          KCNJ14        9.05*E* − 02     −1.40                            

  Potassium inwardly-rectifying channel, subfamily J, member 15, transcript variant 1               NM_170736          KCNJ15        *3.41 E*−*08*    *−150.95*                        

  Potassium inwardly-rectifying channel, subfamily J, member 16, transcript variant 2               NM_170741          KCNJ16        2.22*E* − 01     −1.93                           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(l\) Two-P potassium channels

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                     Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                  Ker → hiPSC    hiPSC → Neuron   
  ----------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Potassium channel, subfamily K, member 1                                      NM_002245          KCNK1         3.02*E* − 04     −1.68                            

  Potassium channel, subfamily K, member 2, transcript variant 1                NM_001017424       KCNK2         3.46*E* − 01     1.57                             

  Potassium channel, subfamily K, member 3                                      NM_002246          KCNK3         9.98*E* − 01     1.00           **2.36**          

  Potassium channel, subfamily K, member 3                                      NM_002246          KCNK3         8.75*E* − 01     −1.10                            

  Potassium channel, subfamily K, member 3                                      NM_002246          KCNK3         5.34*E* − 01     −1.30                            

  Potassium channel, subfamily K, member 3 \[Source: HGNC Symbol; Acc: 6278\]   ENST00000302909    KCNK3         2.53*E* − 01     1.52                             

  Potassium channel, subfamily K, member 4                                      NM_033310          KCNK4         6.21*E* − 01     −1.14          **2.05**          

  Potassium channel, subfamily K, member 5                                      NM_003740          KCNK5         1.16**E** − 14   **29.46**      *−2.35*          *−2.03*

  Potassium channel, subfamily K, member 6                                      NM_004823          KCNK6         *1.22 E*−*06*    *−3.48*        *−2.20*           

  Potassium channel, subfamily K, member 6                                      NM_004823          KCNK6         *2.05 E*−*08*    *−5.11*                          

  Potassium channel, subfamily K, member 6                                      NM_004823          KCNK6         *7.04E−06*       *−5.22*                          

  Potassium channel, subfamily K, member 7, transcript variant A                NM_033347          KCNK7         1.17*E* − 01     −1.52                            

  Potassium channel, subfamily K, member 9                                      NM_016601          KCNK9         6.67*E* − 01     −1.29                            

  Potassium channel, subfamily K, member 10, transcript variant 1               NM_021161          KCNK10        2.63*E* − 01     −1.30                            

  Potassium channel, subfamily K, member 10, transcript variant 2               NM_138317          KCNK10        1.41*E* − 02     1.43                             

  Potassium channel, subfamily K, member 12                                     NM_022055          KCNK12        4.58**E** − 10   **23.40**                       *−5.58*

  Potassium channel, subfamily K, member 13                                     NM_022054          KCNK13        7.65*E* − 01     −1.10                            

  Potassium channel, subfamily K, member 15                                     NM_022358          KCNK15        4.96*E* − 02     −1.50                            

  Potassium channel, subfamily K, member 15                                     NM_022358          KCNK15        9.10*E* − 01     −1.09                            

  Pancreatic potassium channel TALK-1d; alternatively spliced                   AY253147           KCNK16        *2.17 E*−*02*    *−2.43*                          

  Potassium channel, subfamily K, member 17, transcript variant 1               NM_031460          KCNK17        1.87**E** − 11   **28.60**                        

  Potassium channel, subfamily K, member 17, transcript variant 1               NM_031460          KCNK17        1.52**E** − 05   **19.62**                        

  Potassium channel, subfamily K, member 18                                     NM_181840          KCNK18        1.77*E* − 01     1.61                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(m\) Calcium-activated potassium channels

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                                              Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                                                           Ker → hiPSC    hiPSC → Neuron   
  ---------------------------------------------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Potassium large conductance calcium-activated channel, subfamily M, alpha member 1, transcript variant 2               NM_002247          KCNMA1        1.01*E* − 02     1.84                            **2.01**

  Potassium large conductance calcium-activated channel, subfamily M, alpha member 1, transcript variant 1               NM_001014797       KCNMA1        3.19*E* − 01     1.32                             

  Potassium large conductance calcium-activated channel, subfamily M, alpha member 1, transcript variant 2               NM_002247          KCNMA1        3.67**E** − 03   **2.27**                         

  Potassium large conductance calcium-activated channel, subfamily M, alpha member 1, transcript variant 2               NM_002247          KCNMA1        8.53*E* − 02     1.44                             

  Maxi-K channel HSLO                                                                                                    AF349445           KCNMA1        3.04*E* − 01     1.44                             

  Potassium large conductance calcium-activated channel, subfamily M, alpha member 1, transcript variant 2               NM_002247          KCNMA1        2.15*E* − 01     −1.23                           

  Potassium large conductance calcium-activated channel, subfamily M, beta member 1                                      NM_004137          KCNMB1        7.12*E* − 02     −1.41                            

  Potassium large conductance calcium-activated channel, subfamily M, beta member 1                                      NM_004137          KCNMB1        2.23**E** − 06   **7.82**                         

  Potassium large conductance calcium-activated channel, subfamily M, beta member 2, transcript variant 1                NM_181361          KCNMB2        3.36*E* − 01     1.56                             

  Potassium large conductance calcium-activated channel, subfamily M, beta member 2, transcript variant 1                NM_181361          KCNMB2        1.17*E* − 01     1.47                             

  Potassium large conductance calcium-activated channel, subfamily M beta member 3, transcript variant 1                 NM_171828          KCNMB3        1.41**E** − 05   **2.63**                         

  Potassium large conductance calcium-activated channel, subfamily M, beta member 4                                      NM_014505          KCNMB4        8.85**E** − 12   **103.99**                       

  Potassium large conductance calcium-activated channel, subfamily M, beta member 4 \[Source: HGNC Symbol; Acc: 6289\]   ENST00000258111    KCNMB4        9.22**E** − 10   **18.40**                        

  Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1                              NM_002248          KCNN1         3.40**E** − 05   **4.67**                         

  Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, transcript variant 1        NM_021614          KCNN2         1.88**E** − 13   **22.23**      *−3.63*           

  Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, transcript variant 1        NM_002249          KCNN3         2.58**E** − 06   **8.25**                         

  Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, transcript variant 3        NM_001204087       KCNN3         1.11**E** − 07   **15.29**                        

  Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4                              NM_002250          KCNN4         1.06*E* − 02     −1.84                            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(n\) P2X receptors

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                 Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                              Ker → hiPSC    hiPSC → Neuron   
  ----------------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Purinergic receptor P2X, ligand-gated ion channel, 1                                      NM_002558          P2RX1         7.71*E* − 01     1.14                             

  Purinergic receptor P2X, ligand-gated ion channel, 2, transcript variant 4                NM_170683          P2RX2         5.25*E* − 02     −1.66                            

  Purinergic receptor P2X, ligand-gated ion channel, 3                                      NM_002559          P2RX3         2.43*E* − 02     −1.76                            

  Purinergic receptor P2X, ligand-gated ion channel, 4                                      NM_002560          P2RX4         8.68*E* − 01     −1.03                            

  Purinergic receptor P2X, ligand-gated ion channel, 5, transcript variant 1                NM_002561          P2RX5         7.68**E** − 08   **6.97**                        

  Purinergic receptor P2X, ligand-gated ion channel, 5, transcript variant 2                NM_175080          P2RX5         6.13*E* − 02     1.54                             

  Purinergic receptor P2X, ligand-gated ion channel, 6 \[Source: HGNC Symbol; Acc: 8538\]   ENST00000413302    P2RX6         4.13*E* − 01     1.68                             

  Purinergic receptor P2X, ligand-gated ion channel, 7, transcript variant 1                NM_002562          P2RX7         6.13*E* − 01     1.23                             

  Purinergic receptor P2X, ligand-gated ion channel, 7, transcript variant 1                NM_002562          P2RX7         9.17*E* − 01     1.04                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(o\) Transient receptor potential channels

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                                    Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                                                 Ker → hiPSC    hiPSC → Neuron   
  ------------------------------------------------------------------------------------------------------------ ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Polycystic kidney disease 2 (autosomal dominant)                                                             NM_000297          PKD2          7.48*E* − 07     1.79                             

  Polycystic kidney disease 2 (autosomal dominant)                                                             NM_000297          PKD2          2.38*E* − 05     1.98                             

  Polycystic kidney disease 2-like 1                                                                           NM_016112          PKD2L1        1.29**E** − 03   **4.66**                         

  Polycystic kidney disease 2-like 2                                                                           NM_014386          PKD2L2        1.94*E* − 01     1.49                             

  Polycystic kidney disease 2-like 2                                                                           NM_014386          PKD2L2        7.43*E* − 01     1.19                             

  Polycystic kidney disease 2-like 2                                                                           NM_014386          PKD2L2        6.74*E* − 01     1.09                             

  Transient receptor potential cation channel, subfamily A, member 1                                           NM_007332          TRPA1         2.99*E* − 01     1.74                             

  Transient receptor potential cation channel, subfamily A, member 1                                           NM_007332          TRPA1         5.64*E* − 02     2.70                             

  Transient receptor potential cation channel, subfamily C, member 1                                           NM_003304          TRPC1         4.30**E** − 06   **2.01**                         

  Transient receptor potential cation channel, subfamily C, member 3, transcript variant 2                     NM_003305          TRPC3         1.12**E** − 07   **5.78**                        **2.45**

  Transient receptor potential cation channel, subfamily C, member 4, transcript variant alpha                 NM_016179          TRPC4         3.25**E** − 07   **25.38**                        

  Transient receptor potential cation channel, subfamily C, member 5                                           NM_012471          TRPC5         1.20*E* − 01     1.28                             

  Transient receptor potential cation channel, subfamily C, member 6                                           NM_004621          TRPC6         1.21*E* − 01     2.33                             

  Transient receptor potential cation channel, subfamily C, member 7, transcript variant 1                     NM_020389          TRPC7         6.18*E* − 01     −1.36                            

  Transient receptor potential cation channel, subfamily M, member 1                                           NM_002420          TRPM1         2.29*E* − 01     1.31                             

  Transient receptor potential cation channel, subfamily M, member 2, transcript variant 1                     NM_003307          TRPM2         1.22*E* − 01     1.97                             

  Transient receptor potential cation channel, subfamily M, member 2, transcript variant 1                     NM_003307          TRPM2         5.04*E* − 02     2.53                             

  Transient receptor potential cation channel, subfamily M, member 3, transcript variant 7                     NM_206948          TRPM3         3.04**E** − 09   **10.69**                        

  Transient receptor potential cation channel, subfamily M, member 3 \[Source: HGNC\                           ENST00000354500    TRPM3         2.34**E** − 03   **3.74**                         
  Symbol; Acc: 17992\]                                                                                                                                                                           

  Transient receptor potential cation channel, subfamily M, member 3, transcript variant 7                     NM_206948          TRPM3         3.41**E** − 06   **6.23**                         

  Transient receptor potential cation channel, subfamily M, member 3, transcript variant 9                     NM_001007471       TRPM3         7.23*E* − 01     1.13                             

  Transient receptor potential cation channel, subfamily M, member 3, transcript variant 9                     NM_001007471       TRPM3         1.54**E** − 05   **2.60**                        

  Transient receptor potential cation channel, subfamily M, member 4, transcript variant 1                     NM_017636          TRPM4         3.72*E* − 02     −1.89                            

  Transient receptor potential cation channel, subfamily M, member 5                                           NM_014555          TRPM5         8.21*E* − 01     −1.08                            

  Transient receptor potential cation channel, subfamily M, member 6, transcript variant a                     NM_017662          TRPM6         3.80*E* − 01     1.64                             

  Transient receptor potential cation channel, subfamily M, member 6, transcript variant a                     NM_017662          TRPM6         9.10*E* − 01     1.05                             

  Transient receptor potential cation channel, subfamily M, member 6, transcript variant a                     NM_017662          TRPM6         5.32**E** − 07   **5.59**                         

  Transient receptor potential cation channel, subfamily M, member 6, transcript variant a                     NM_017662          TRPM6         3.32*E* − 01     1.36                             

  Transient receptor potential cation channel, subfamily M, member 7                                           NM_017672          TRPM7         2.16*E* − 02     −1.25                            

  Transient receptor potential cation channel, subfamily M, member 7                                           NM_017672          TRPM7         3.64*E* − 03     −1.38                            

  Transient receptor potential cation channel, subfamily M, member 8                                           NM_024080          TRPM8         2.04*E* − 01     1.89                             

  Transient receptor potential cation channel, subfamily V, member 1, transcript variant 3                     NM_080706          TRPV1         3.59*E* − 05     1.92                             

  Transient receptor potential cation channel, subfamily V, member 1, transcript variant 3                     NM_080706          TRPV1         4.14**E** − 05   **2.25**                         

  Transient receptor potential cation channel, subfamily V, member 2                                           NM_016113          TRPV2         8.02**E** − 08   **4.68**                         

  Transient receptor potential cation channel, subfamily V, member 3                                           NM_145068          TRPV3         4.64*E* − 01     1.35                             

  Transient receptor potential cation channel, subfamily V, member 3                                           NM_145068          TRPV3         1.35*E* − 01     −2.39                            

  Transient receptor potential cation channel, subfamily V, member 4, transcript variant 2                     NM_147204          TRPV4         4.33*E* − 01     1.39                             

  Transient receptor potential cation channel, subfamily V, member 5, (cDNA clone MGC: 34269 IMAGE: 5186668)   BC034740           TRPV5         1.00*E* − 01     1.38                             

  Transient receptor potential cation channel, subfamily V, member 5                                           NM_019841          TRPV5         3.14*E* − 01     −1.40                            

  Transient receptor potential cation channel, subfamily V, member 6                                           NM_018646          TRPV6         1.57*E* − 01     −1.38                            
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(p\) Voltage-gated sodium channels

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                                   Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                                                Ker → hiPSC    hiPSC → Neuron   
  ------------------------------------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Sodium channel, voltage-gated, type I, alpha subunit, transcript variant 2                  NM_006920          SCN1A         1.98*E* − 01     1.54                             

  Sodium channel, voltage-gated, type I, beta, transcript variant b                           NM_199037          SCN1B         9.95*E* − 01     −1.00                            

  Sodium channel, voltage-gated, type II, alpha subunit, transcript variant 1                 NM_021007          SCN2A         4.16*E* − 01     1.62           **5.00**          

  Sodium channel, voltage-gated, type II, beta                                                NM_004588          SCN2B         3.61*E* − 01     −1.58                            

  Sodium channel, voltage-gated, type II, beta                                                NM_004588          SCN2B         *8.16 E*−*04*    *−2.41*                         

  Sodium channel, voltage-gated, type III, alpha subunit, transcript variant 1                NM_006922          SCN3A         2.87*E* − 01     −2.00          **2.85**          

  Sodium channel, voltage-gated, type III, alpha subunit, transcript variant 1                NM_006922          SCN3A         1.89*E* − 01     1.49                             

  Sodium channel, voltage-gated, type III, beta, transcript variant 1                         NM_018400          SCN3B         8.74*E* − 01     −1.06          **4.70**          

  Sodium channel, voltage-gated, type III, beta, transcript variant 1                         NM_018400          SCN3B         1.57*E* − 01     −1.46                            

  Sodium channel, voltage-gated, type III, beta, transcript variant 1                         NM_018400          SCN3B         1.56*E* − 01     1.96                             

  Sodium channel, voltage-gated, type IV, alpha subunit                                       NM_000334          SCN4A         1.62**E** − 08   **9.91**                         

  Sodium channel, voltage-gated, type IV, beta, transcript variant 1                          NM_174934          SCN4B         *3.25 E*−*04*    *−3.66*                          

  Sodium channel, voltage-gated, type V, alpha subunit, transcript variant 1                  NM_198056          SCN5A         2.43**E** − 08   **14.10**                        

  Sodium channel, voltage-gated, type V, alpha subunit, transcript variant 2                  NM_000335          SCN5A         4.93*E* − 02     1.95                             

  Sodium channel, voltage-gated, type VII, alpha                                              NM_002976          SCN7A         4.49*E* − 03     1.63                             

  Sodium channel, voltage-gated, type VII, alpha                                              NM_002976          SCN7A         2.07*E* − 01     1.72                             

  Sodium channel, voltage gated, type VIII, alpha subunit, transcript variant 1               NM_014191          SCN8A         1.89**E** − 09   **15.61**                        

  Sodium channel, voltage gated, type VIII, alpha subunit, transcript variant 1               NM_014191          SCN8A         4.06**E** − 07   **11.23**                        

  Sodium channel, voltage-gated, type IX, alpha subunit                                       NM_002977          SCN9A         4.08**E** − 08   **11.51**                        

  Sodium channel, voltage-gated, type IX, alpha subunit                                       NM_002977          SCN9A         1.62*E* − 01     1.66                             

  Sodium channel, voltage-gated, type IX, alpha subunit                                       NM_002977          SCN9A         3.38**E** − 03   **2.57**                         

  Sodium channel, voltage-gated, type X, alpha subunit                                        NM_006514          SCN10A        4.06*E* − 01     1.35                             

  Sodium channel, voltage-gated, type XI, alpha subunit                                       NM_014139          SCN11A        3.02*E* − 01     1.57                             

  Sodium channel, voltage-gated, type XI, alpha subunit \[Source: HGNC Symbol; Acc: 10583\]   ENST00000444237    SCN11A        8.83*E* − 03     1.94                             
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(q\) Nonvoltage-gated sodium channels

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                         Accession number   Gene symbol   P                Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                                      Ker → hiPSC    hiPSC → Neuron   
  ----------------------------------------------------------------- ------------------ ------------- ---------------- -------------- ---------------- ------------------------
  Sodium channel, nonvoltage-gated 1 alpha, transcript variant 1    NM_001038          SCNN1A        1.33**E** − 09   **51.49**      *−21.13*         *−10.71*

  Sodium channel, nonvoltage-gated 1, beta                          NM_000336          SCNN1B        2.11*E* − 01     1.64                             

  Sodium channel, nonvoltage-gated 1, beta                          NM_000336          SCNN1B        5.52*E* − 01     1.09                             

  Sodium channel, nonvoltage-gated 1, delta, transcript variant 1   NM_001130413       SCNN1D        8.43*E* − 02     1.49                             

  Sodium channel, nonvoltage-gated 1, gamma                         NM_001039          SCNN1G        2.33*E* − 01     1.59                             

  Gamma subunit of epithelial amiloride-sensitive sodium channel    X87160             SCNN1G        3.99*E* − 01     1.27                            
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(r\) Two-pore channels

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                          Accession number   Gene symbol   P               Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                                      Ker → hiPSC    hiPSC → Neuron   
  -------------------------------------------------- ------------------ ------------- --------------- -------------- ---------------- ------------------------
  Two-pore segment channel 1, transcript variant 1   NM_001143819       TPCN1         6.20*E* − 04    −1.76                            

  Two-pore segment channel 1, transcript variant 2   NM_017901          TPCN1         *1.71 E*−*03*   *−2.10*                          

  Two-pore segment channel 1, transcript variant 2   NM_017901          TPCN1         *3.55 E*−*04*   *−2.44*                          

  Two-pore segment channel 1, transcript variant 1   NM_001143819       TPCN1         8.06*E* − 03    −1.83                            

  Two-pore segment channel 2                         NM_139075          TPCN2         5.06*E* − 01    −1.15                            
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

\(s\) Zinc-activated ligand-gated ion channels

  --------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                 Accession number   Gene symbol   P              Fold change\   Fold change\     Fold change hiPSC → CM
                                                                                            Ker → hiPSC    hiPSC → Neuron   
  ----------------------------------------- ------------------ ------------- -------------- -------------- ---------------- ------------------------
  Zinc-activated ligand-gated ion channel   NM_180990          ZACN          9.24*E* − 02   1.45                             

  --------------------------------------------------------------------------------------------------------------------------------------------------

[^1]: Academic Editor: Michael Levin
